Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue FrançaiseP Jacoulet, A Depierre, D Moro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 3, 2005
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatinJ-L Pujol, J-L Breton, R Gervais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trialB Besse, J Mazières, L Ribassin-Majed, et al.
Revue Des Maladies Respiratoires|May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]V Westeel, M P Lebitasy, M Mercier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF)S Couraud, A B Cortot, L Greillier, et al.
Bulletin Du Cancer|May 24, 2001
[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma]E Bardet, D Moro-Sibilot, T Le Chevalier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 28, 2001
[Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy]E Touboul, J L Lagrange, S Theobald, et al.
Pageof 21